TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Mean Tosm during exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Medication nonadherence
Endpoint domain: Adverse events/effects
Primary endpoint: bladder cancer incidence
Endpoint domain: Mortality/survival
Primary endpoint: mean plasma vitamin C concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasma concentrations of alpha-, delta- and gamma-tocotrienols
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Systolic blood pressure drop
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Diastolic blood pressure drop
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Satisfactory level of surgical anaesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inhibition of pSTAT5
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Decline in CD4+ and CD8+ effector and central memory T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Preservation of immunologic response to tetanus toxoid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Average daily wear hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean number of nonzero activity count minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of valid days
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: MRSA-free status 30 days after treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: post-operative morbidity
Endpoint domain: Adverse events/effects
Primary endpoint: median length of hospitalisation
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Serum phosphorus reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in serum FGF-23
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Bone formation markers increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 24-h post-transfusion recovery of RBCs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of any grade HFSR
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of grade > 2 HFSR
Endpoint domain: Adverse events/effects
Primary endpoint: Median time to first occurrence of HFSR
Endpoint domain: Adverse events/effects
Primary endpoint: anatomy comprehension
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: mean grade change of coronary stenoses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: proportion of new occlusions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Understanding of role in OR exsanguination emergency
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Activation of the exsanguination protocol
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to complete clinically significant tasks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Return to ordinary dental treatment
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: T2 lesion count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Annualized relapse rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: T1/2 (half-life)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tmax (time to maximum concentration)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax (maximum concentration)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 12-month worry reduction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: FAAM score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Symptomatic nonunion rate
Endpoint domain: Adverse events/effects
Primary endpoint: Endothelial cell density reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: UACR change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Specificity of C-Tb test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Improved health status (PGIC score)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: BMD of lumbar spine and femoral neck
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum osteocalcin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum calcium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fever burden reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percent time febrile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percent time normothermic
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Musculoskeletal Functional Assessment Survey score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Ankle-Hindfoot Scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: DOX availability in gingival crevicular fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proximal hair shaft tapering
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Decrease in normal telogen hairs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: total SGRQ score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: CPR theoretical knowledge score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Compressions per minute
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects with TNA NF50 value ≥ 0.56
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in QTcF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Adequate clinical and parasitological response (ACPR) rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total power and high-frequency power preservation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Range of motion restriction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of 2-PE and 1-PE adducts in exposed workers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of periodontal pockets ≥4 mm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distalization of maxillary first molars
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of molar movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anchorage loss of the anterior dental unit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean duration of cylinder use (minutes per day)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Persistence of serum bactericidal antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Booster response to MCV‐4
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: self-soothing behavior
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: DBS lead placement error
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: migration of DBS lead
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cure rate at 10 days after therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: New infections at 1 month follow-up
Endpoint domain: Adverse events/effects
Primary endpoint: MoCA total scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Serum S-100β levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC(ss(per week))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total hospitalization period
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Quality of discussion
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Participants' appraisal of the discussion
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ALT flare
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: opioid antagonist effects
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: precipitated withdrawal
Endpoint domain: Adverse events/effects
Primary endpoint: posttraumatic stress symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: team efficacy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: serious asthma-related event
Endpoint domain: Adverse events/effects
Primary endpoint: severe asthma exacerbation
Endpoint domain: Adverse events/effects
Primary endpoint: HIV-positive status at birth
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of days with missed doses of psychotropic medications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of days with missed doses of nonpsychotropic medications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in cytokine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: NK-cell histone acetylation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: enhanced coagulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Prescription of indicated medications
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in EAPP score on VAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Point prevalence rate for AF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Accuracy of heart rate determination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Follow-up with PCP
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Median time to next PCP visit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intubating conditions (excellent or good)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Partial blockade of the adductor pollicis muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Onset time of muscle relaxation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in stool form
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Reduction in vomiting episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Short time for EN infusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Baseline binding potentials
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Red blood cell count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Proportion of patients showing improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality in hospital
Endpoint domain: Mortality/survival
Primary endpoint: success rate of insertion at first attempt
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of blood staining
Endpoint domain: Adverse events/effects
Primary endpoint: premature gastric phase III duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: intraballoon volume decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Coefficient of variation for mean RNFL thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of new bone formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Average blood oxygen saturation (MSaO₂)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Activation in frontal regions in response to food cues
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: myocardial and leg tissue uptake of glutamate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: uptake of lactate in the heart
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: negative arterial‐venous differences of amino acids and free fatty acids
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean reduction in GGT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Plasma non-suppressible PTH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Plasma total calcium at t = 0
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Plasma total calcium at PTH set-point
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: median number of days of good clinical control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of exclusion due to partly controlled asthma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality from AAAs
Endpoint domain: Mortality/survival
Primary endpoint: levels of alkaline phosphatase, alanine transaminase and aspartate transaminase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in women's knowledge of screening tests
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Increase in type I collagen fibers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes